Skip to main content
Veterinary Medicines

Raboral V-RG Ēsma lapsām

Authorised
  • Vaccinia virus, expressing glycoprotein gene of rabies virus, Live

Product identification

Medicine name:
Raboral V-RG Ēsma lapsām
Active substance:
  • Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Target species:
  • Fox
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
    100000000.00
    50% cell culture infectious dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07BD
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/NRP/03/1613
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 22/03/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 22/03/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 22/03/2024